Despite present therapies of hypertransfusion and chelation of iron with desferrioxamine (DFO), patients with thalassemia major continue to succumb in their early to mid twenties to fatal iron ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback